LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the appointment of Mark H.N. Corrigan, M.D., to its Board of Directors. Dr. Corrigan is Executive Vice President, Research & Development at Sepracor, Inc. He also serves on the board of NeuroMed Technologies, Inc.
